Acquiring Company
FHC Group
Acquired Company
Activo Health
Description
FHC Group has acquired Activo Health from Afrocentric to enhance its presence in Africa, emphasizing sterile injectables. The deal included an upfront payment of R100m and future performance-based earn-outs. FHC plans to establish a manufacturing facility in South Africa, leveraging the country's stable regulatory environment.
Don't miss FHC Group's next move
Get an email the moment FHC Group makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Activo Health?
Activo Health was acquired by FHC Group, based in Portugal. The deal was reported on September 8, 2026. FHC is a privately held Portuguese pharmaceutical group that owns Laboratórios Basi. It reported a turnover of about €543m in 2025. FHC Group is privately held and operates in Biotechnology.
When did FHC Group acquire Activo Health?
FHC Group's acquisition of Activo Health was reported on September 8, 2026. FHC Group has acquired Activo Health from Afrocentric to enhance its presence in Africa, emphasizing sterile injectables. The deal included an upfront payment of R100m and future performance-based earn-outs. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Activo Health do?
Activo Health is a pharmaceutical company that sells a range of nonprescription products. It has recently begun bidding for state contracts and currently supplies several medicines to the state. It is privately held, operating in Biotechnology, and is based in South Africa.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.